Latest papers

Irreversible striatal neuroimaging abnormalities secondary to prolonged, uncontrolled diabetes mellitus in the setting of progressive focal neurological symptoms.

Psychotropic medication-induced rabbit syndrome.

The FRAGAMP study: environmental and genetic factors in Parkinson's disease, methods and clinical features.

Oral and infusion levodopa-based strategies for managing motor complications in patients with Parkinson's disease.

Anti-N-methyl-D-aspartate receptor antibodies: a potentially treatable cause of encephalitis in the intensive care unit.

Pain and dyskinesia in Parkinson's disease.

Evaluation of the efficacy and safety of adjuvant treatment to levodopa therapy in Parkinson s disease patients with motor complications.

Discourse coherence and cognition after stroke: A dual task study

Clinical experiences with levodopa methylester (melevodopa) in patients with Parkinson disease experiencing motor fluctuations: an open-label observational study.

Stimulation-induced dyskinesia in the early stage after subthalamic deep brain stimulation.

Treatment strategies for dystonia.

Classification of cerebral palsy: association between gender, age, motor type, topography and Gross Motor Function.

[Role of zonisamid in treating epilepsy, Parkinson disorders and other neurological diseases].

Determination of brain iron content in patients with Parkinson's disease using magnetic susceptibility imaging.

[Unique clinical features and pathophysiology of anti-NMDA receptor encephalitis].

Aerobic exercise improves cognition and motor function poststroke.

Dopamine gene therapy for Parkinson's disease in a nonhuman primate without associated dyskinesia.

Persistent mirror movement associated with disabling pain and sleep arousal disorder: a case report.

Movement disorders should be a criterion for schizophrenia in DSM-V.

[Non-pharmacological influencing factors of motor complications in Parkinson's disease: a systematic review].